Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0NF3E
|
||||
Former ID |
DNC005884
|
||||
Drug Name |
2-(4-nitro-1H-benzo[d]imidazol-2-yl)quinoxaline
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C15H9N5O2
|
||||
Canonical SMILES |
C1=CC=C2C(=C1)N=CC(=N2)C3=NC4=C(N3)C=CC=C4[N+](=O)[O-]
|
||||
InChI |
1S/C15H9N5O2/c21-20(22)13-7-3-6-11-14(13)19-15(18-11)12-8-16-9-4-1-2-5-10(9)17-12/h1-8H,(H,18,19)
|
||||
InChIKey |
RDSFCGCNTCJZOD-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Adenosine A3 receptor | Target Info | Inhibitor | [1] | |
Reactome | Adenosine P1 receptors | ||||
G alpha (i) signalling events | |||||
WikiPathways | Nucleotide GPCRs | ||||
GPCRs, Class A Rhodopsin-like | |||||
GPCRs, Other | |||||
References | |||||
REF 1 | J Med Chem. 2005 Dec 29;48(26):8253-60.2-(Benzimidazol-2-yl)quinoxalines: a novel class of selective antagonists at human A(1) and A(3) adenosine receptors designed by 3D database searching. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.